Baird Medical Investment Holdings Limited (NASDAQ:BDMD) shares, rose in value on Thursday, January 02, with the stock price down by -32.63% to the previous day’s close as strong demand from buyers drove the stock to $5.12.
Actively observing the price movement in the last trading, the stock closed the session at $7.60, falling within a range of $3.772 and $5.7999. The value of beta (5-year monthly) was 0.142. Referring to stock’s 52-week performance, its high was $13.52, and the low was $1.05. On the whole, BDMD has fluctuated by 113.33% over the past month.
With the market capitalization of Baird Medical Investment Holdings Limited currently standing at about $181.50 million, investors are eagerly awaiting this quarter’s results, scheduled for in February.
The stock’s technical analysis shows that the price of BDMD currently trading nearly 132.83% and 104.33% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.18, while the 7-day volatility ratio is showing 140.35% which for the 30-day chart, stands at 51.55%. Furthermore, Baird Medical Investment Holdings Limited (BDMD)’s beta value is -0.68, and its average true range (ATR) is 1.19.
A comparison of Baird Medical Investment Holdings Limited (BDMD) with its peers suggests the former has fared considerably weaker in the market. BDMD showed an intraday change of -32.63% in last session, and over the past year, it shrunk by -50.86%%.
Data on historical trading for Baird Medical Investment Holdings Limited (NASDAQ:BDMD) indicates that the trading volumes over the past 10 days have averaged 9.13 and over the past 3 months, they’ve averaged 1.46 million. According to company’s latest data on outstanding shares, there are 7.29 million shares outstanding.
Baird Medical Investment Holdings Limited’s shares belong to company insiders and institutional investors own 89.64% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 24112.0 shares as on 2024-12-13, resulting in a short ratio of 0.67. The stock has fallen by -32.63% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BDMD stock heading into the next quarter.
